BR1100311A - Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica - Google Patents

Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica

Info

Publication number
BR1100311A
BR1100311A BR1100311-1A BR1100311A BR1100311A BR 1100311 A BR1100311 A BR 1100311A BR 1100311 A BR1100311 A BR 1100311A BR 1100311 A BR1100311 A BR 1100311A
Authority
BR
Brazil
Prior art keywords
pct
antimitotic
alkaloids
medication
binary
Prior art date
Application number
BR1100311-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Original Assignee
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100311(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jean-Claude Jacquesy, Jacques Fahy, Christian Berrier, Dennis Bigg, Marie Paule Jouannetaud, Fabien Zunino, Anna Kruczynski, Robert Kiss filed Critical Jean-Claude Jacquesy
Publication of BR1100311A publication Critical patent/BR1100311A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR1100311-1A 1993-07-21 1997-04-22 Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica BR1100311A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308948A FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Publications (1)

Publication Number Publication Date
BR1100311A true BR1100311A (pt) 1999-08-31

Family

ID=9449457

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100311-1A BR1100311A (pt) 1993-07-21 1997-04-22 Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica

Country Status (15)

Country Link
US (1) US5620985A (enExample)
EP (1) EP0710240B1 (enExample)
JP (1) JP3606872B2 (enExample)
AT (1) ATE146477T1 (enExample)
AU (1) AU693460B2 (enExample)
BR (1) BR1100311A (enExample)
CA (1) CA2167694C (enExample)
DE (2) DE69401216T2 (enExample)
DK (1) DK0710240T3 (enExample)
ES (1) ES2097659T3 (enExample)
FR (2) FR2707988B1 (enExample)
GR (1) GR3022659T3 (enExample)
LU (1) LU91660I2 (enExample)
NZ (2) NZ269172A (enExample)
WO (1) WO1995003312A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737208A1 (fr) * 1995-07-28 1997-01-31 Pf Medicament Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
FR2783522A1 (fr) * 1998-09-21 2000-03-24 Pf Medicament Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1694330A4 (en) 2003-12-04 2009-06-24 Amr Technology Inc DERIVATIVES OF VINORELBINE
NZ547370A (en) 2003-12-04 2010-09-30 Amr Technology Inc Vinca derivatives
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
ATE507240T1 (de) 2004-03-05 2011-05-15 Vegenics Pty Ltd Materialien und verfahren für wachstumsfaktorbindende konstrukte
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
CA2642717C (en) * 2006-02-17 2015-08-18 Novacea, Inc. Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
CN101108859A (zh) * 2006-07-17 2008-01-23 上海恒瑞医药有限公司 长春碱类化合物、其制备方法及其在医药上的用途
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
CN101235046B (zh) * 2007-01-29 2010-09-08 中国科学院上海药物研究所 长春碱衍生物、其制备方法和用途、以及包含该衍生物的药物组合物
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
SG172359A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside phosphoramidates
NZ593647A (en) 2008-12-23 2013-08-30 Gilead Pharmasset Llc Synthesis of purine nucleosides
ES2575160T3 (es) 2010-03-15 2016-06-24 The Board Of Trustees Of The University Of Illinois Inhibidores de las interacciones que unen la subunidad alfa de la beta integrina-proteína G
JP2013527145A (ja) 2010-03-31 2013-06-27 ギリード・ファーマセット・エルエルシー リン含有活性化剤の立体選択的合成
US9029502B2 (en) 2010-12-20 2015-05-12 The Regents Of The University Of Michigan Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
CN103788117A (zh) * 2012-10-30 2014-05-14 何小解 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺
HU230462B1 (hu) 2013-05-30 2016-07-28 Richter Gedeon Nyrt. Új bisz-indol alkaloidok mint rákellenes gyógyszerek
AU2015205995A1 (en) 2014-01-15 2016-07-28 Centre National De La Recherche Scientifique (Cnrs) Water soluble 4-azapodophyllotoxin analogs
CN107683289B (zh) 2015-01-26 2021-08-06 芝加哥大学 IL13Rα2结合剂和其在癌症治疗中的用途
JP6912386B2 (ja) 2015-01-26 2021-08-04 ザ ユニバーシティー オブ シカゴ 癌特異的なIL13Rα2を認識するCAR T細胞
US20190092792A1 (en) * 2016-03-09 2019-03-28 Synbias Pharma Ag Vinorelbine monotartrate and its pharmaceutical use
EP3481422A1 (en) 2016-07-06 2019-05-15 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination
US20200254037A1 (en) 2017-08-07 2020-08-13 Amgen Inc. Treatment of triple negative breast cancer or colorectal cancer with liver metastases with an anti pd-l1 antibody and an oncolytic virus
MX2021011330A (es) 2019-03-20 2021-12-10 Univ California Anticuerpos de claudina-6 y conjugados de fármacos.
JP7682797B2 (ja) 2019-03-20 2025-05-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア クローディン6二重特異性抗体
JP2022530241A (ja) 2019-04-30 2022-06-28 インスチトゥート デ メディシーナ モリクラール ジョアン ロボ アントゥネス Cdk阻害剤と組み合わせたrank経路阻害剤
WO2020263793A1 (en) 2019-06-24 2020-12-30 Amgen Inc. Inhibition of sirp-gamma for cancer treatment
FR3140369B1 (fr) 2022-10-04 2025-07-25 Univ Poitiers Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (enExample) * 1974-12-30 1978-07-21 Anvar
US4110330A (en) * 1977-05-27 1978-08-29 Eli Lilly And Company 5'-Acetonylvincristine and related compounds
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4320058A (en) * 1980-12-29 1982-03-16 Eli Lilly And Company 20'-Hydroxyvinblastine and related compounds
HU193772B (en) * 1985-06-12 1987-11-30 Richter Gedeon Vegyeszet Process for producing new nitro-bis-indole derivatives

Also Published As

Publication number Publication date
ATE146477T1 (de) 1997-01-15
EP0710240B1 (fr) 1996-12-18
FR2707988A1 (fr) 1995-01-27
DE69401216T2 (de) 1997-07-03
FR10C0012I1 (enExample) 2010-04-16
CA2167694A1 (fr) 1995-02-02
DE69401216D1 (de) 1997-01-30
AU7266694A (en) 1995-02-20
LU91660I2 (fr) 2010-05-10
GR3022659T3 (en) 1997-05-31
EP0710240A1 (fr) 1996-05-08
JPH09500634A (ja) 1997-01-21
NZ328612A (en) 2000-05-26
WO1995003312A1 (fr) 1995-02-02
FR10C0012I2 (enExample) 2011-04-01
CA2167694C (fr) 2007-03-06
US5620985A (en) 1997-04-15
JP3606872B2 (ja) 2005-01-05
ES2097659T3 (es) 1997-04-01
DK0710240T3 (da) 1997-06-02
FR2707988B1 (fr) 1995-10-13
NZ269172A (en) 1997-10-24
AU693460B2 (en) 1998-07-02
DE122010000012I1 (de) 2010-07-08

Similar Documents

Publication Publication Date Title
BR1100311A (pt) Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica
DK0749432T3 (da) 9-deoxotaxan-forbindelser
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
ATE208777T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
ATE304543T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
RU94036761A (ru) Производные галантамина и фармацевтическая композиция
PL306402A1 (en) Thiazole derivatives, method of obtaining them and pharmaceutical preparations containing such derivatives
ATE170530T1 (de) Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten
BR9807944A (pt) Derivados antimitóticos dos alcalóides da vinca, compostos, processo para preparar os compostos, processo para preparar a 4'-desóki-20', 20'-difluorovinblastina, processo para preparar a 20', 20'-diflúoro-3', 4'-diidrovinorrelbina ou vinflunina, produtos medicinais, e, composição farmacêutica
DE69907419D1 (en) Antitumorwirkstoffe
PT728138E (pt) Derivados de antraciclina
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
PT98976A (pt) Processo para a preparacao de heteroarilmetilbenzenos
RU94040719A (ru) 2,3,4,5-тетрагидро-1h-3-бензазепины, фармацевтическая композиция, способ лечения и способ получения
ATE186214T1 (de) Verwendung von rosmanolderivaten zur herstellung von antiradikalischen und/oder antilipoperoxidativen und/oder hepatotropen arzneistoffen
RU94033096A (ru) Соединение, способ лечения и фармацевтическая композиция
RU94026088A (ru) Способ лечения шока и способ ингибирования продуцирования альфа фактора некроза опухоли
RU95112507A (ru) Новые цефемовые соединения, способ их получения, фармкомпозиция, способ лечения и промежуточные продукты
TH19877A (th) อนุพันธ์แอนธราไซคลิโนน
YU5796A (sh) Supstituisani derivati indola, postupak za njihovu izradu, lekovi koji ih sadrže i njihova upotreba
IT1261958B (it) 2-(sostituite immino)-tiazolidine e procedimento per la loro preparazione e loro impiego quali antianginose e/o analgesiche

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
BAP Processing applications according to articles 230 and 231 of law 9.279/96: publication of application for third parties submission of comments
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96